Multiple Sclerosis Trial, Not Yet Recruiting NCT07589062 Sponsor: New York University Abu Dhabi Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07589062
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with multiple sclerosis (MS) using a standard set of medical guidelines called the McDonald criteria.
  • People whose MS allows them to walk, with or without some assistance (based on a disability score of 6.5 or below on a standard MS scale).
  • People who have been on a stable MS treatment for at least 3 months without changes.
  • People aged between 18 and 50 years old.
  • People who can communicate in English or Arabic.
  • People who have been cleared by a doctor to take part in a structured exercise program.
  • People who are able to walk, sit, stand on their own, and do light to moderate movement, even if some adjustments are needed.
  • People who are comfortable enough with technology to use a bilingual mobile app called HEAL MS.
  • People who have access to a computer to take part in online sessions.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with significant memory or thinking difficulties that would make it hard to use the app or understand the program.
  • People who have had an MS relapse (a flare-up of symptoms) in the past 3 months.
  • People who are pregnant or planning to become pregnant.
  • People with a psychiatric (mental health) condition that is not currently being managed or treated.
  • People who have other immune system conditions, long-term inflammatory conditions, or metabolic diseases (such as uncontrolled diabetes) (confirm with trial site).
  • People who are already taking part in another program focused on lifestyle changes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Youssef Idaghdour, Professor, New York University Abu Dhabi

Phone: +971501821961

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
New York University Abu Dhabi
Registry
ClinicalTrials.gov
Start date
15 April 2026
Est. completion
15 November 2027

Where this trial is recruiting

🇦🇪 United Arab Emirates

Primary endpoints

Recruitment Rate (Number of Participants Enrolled per Month); Retention Rate (Percentage of Participants Completing All Study Assessments); Exercise Adherence (Percentage of Completed Scheduled Exercise Sessions); Mobile Application Engagement (Average Daily Completion Rate of App-Based Logs); Acceptability of HEAL MS Intervention (Participant Satisfaction Score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov